Koers Acerus Pharmaceuticals Corporation Toronto S.E.
Aandelen
ASP
CA00444G4051
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 01-05-18 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 17-07-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 09-09-13 |
Borys Chabursky
BRD | Director/Board Member | - | 20-12-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+42,60% | 739 mld. | |
+32,34% | 598 mld. | |
-5,74% | 353 mld. | |
+17,79% | 318 mld. | |
+3,37% | 285 mld. | |
+16,47% | 240 mld. | |
+9,26% | 210 mld. | |
-5,07% | 206 mld. | |
+6,74% | 164 mld. |